CompletedPhase 1NCT01106872

Bevacizumab, Chemotherapy and Valproic Acid in Advanced Sarcomas

Studying Soft tissue sarcoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Mohammed M Milhem
Principal Investigator
Mohammed Milhem, MD
University of Iowa
Intervention
Bevacizumab, Gemcitabine, Docetaxel and Valproic Acid(drug)
Enrollment
47 target
Eligibility
18-99 years · All sexes
Timeline
20102017

Study locations (1)

Collaborators

Genentech, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01106872 on ClinicalTrials.gov

Other trials for Soft tissue sarcoma

Additional recruiting or active studies for the same condition.

See all trials for Soft tissue sarcoma

← Back to all trials